Merge Labs is an early-stage research organisation developing non-implant brain–computer interface approaches based on ultrasound as a deep-reaching neural access modality. The company traces its origins to Forest Neurotech, a nonprofit research effort incubated by Convergent Research to address foundational constraints in ultrasound-based neural interfaces.

Merge positions its work around combining ultrasound with biological interaction to enable neural sensing and modulation without penetrating brain tissue. While no system architecture or target applications have been disclosed, the approach is framed as an alternative to electrode-based BCIs and is focused on modality development rather than near-term products or clinical programs.

The organisation operates in an experimental, long-horizon research context, with backing from OpenAI and other technology investors. Its positioning sits at the intersection of neurotechnology, biotechnology, and artificial intelligence, reflecting an emphasis on foundational interface research and interpretation layers rather than immediate clinical or consumer deployment.